BNY Mellon Global Equity Income - Y holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
BNY Mellon Global Equity Income Fund - Class Y DEQYX
- NAV / 1-Day Return 13.55 / +0.44 %
- Total Assets 198.8M
-
Adj. Expense Ratio
0.920%
- Expense Ratio 0.920%
- Distribution Fee Level Above Average
- Share Class Type Institutional
- Category Global Large-Stock Value
- Investment Style Large Value
- Min. Initial Investment 1M
- Status Open
- TTM Yield 1.95%
- Turnover 54%
USD | NAV as of Oct 07, 2026 | 1-Day Return as of Oct 07, 2026, 12:11 AM GMT+0
Morningstar’s Analysis DEQYX
Will DEQYX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 23.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Gilead Sciences Inc | 2.99 | 6M | Healthcare |
CME Group Inc Class A | 2.69 | 6M | Financial Services |
AIA Group Ltd | 2.50 | 5M | Financial Services |
UnitedHealth Group Inc | 2.33 | 5M | Healthcare |
GSK PLC | 2.25 | 5M | Healthcare |
Texas Instruments Inc | 2.23 | 5M | Technology |
Smurfit WestRock PLC | 2.22 | 5M | Consumer Cyclical |
Elevance Health Inc | 2.20 | 5M | Healthcare |
Expand Energy Corp Ordinary Shares - New | 2.16 | 5M | Energy |
Barclays PLC | 2.12 | 5M | Financial Services |